Boehringer Ingelheim GmbH's new India chief, Vani Manja, has outlined a roadmap to sustain the “remarkable” pace of growth the private German company has seen on the local market,, and hopes to steer the firm into the top five position among multinationals in the country over the next few years.
Manja, BI India’s first woman country managing director, outlined at a media roundtable a range of priority areas in 2021 to move up the ranks among foreign firms, including building on the company’s strong position in the diabetes segment by developing “holistic care models”,
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?